half dose of tirzepatide Can you take every 5 days? What the pharmacology actually says Lilly launches lower-price weight-loss drug

Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: mechanisms and therapeutic potential

Your genetic responder profile influences whether you'll trend toward the higher or lower end of this range

An interim analysis in July 2025 showed lutikizumab achieved numerically higher endoscopic improvement rates compared to adalimumab but failed to demonstrate sufficient differentiation for statistical significance, leading the pharmaceutical company to discontinue monotherapy development in UC

Structured logbooks designed for diabetes management work well for GLP-1 tracking, and many endocrinology practices provide templates

If you believe you have copper toxicity, and would like to be tested, contact our medical office for an appointment